在非酒精性脂肪肝疾病设置中控制心血管风险
Paula Luque Linero1, Luis Castilla-Guerra1,2
1Vascular Risk Unit, Department of Internal Medicine, Hospital Virgen Macarena Seville, Spain.
非酒精性脂肪肝 (NAFLD) 影响全球32%以上的成年人,是心血管疾病的重要,独立的风险因素. 生活方式的改变和管理相关的条件是关键,但需要更多的研究,以获得最佳的预防策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 心脏病学 心脏病学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个普遍的全球健康问题,影响超过32%的成年人.
- 在工业化国家,NAFLD越来越普遍,通常与肥胖,2型糖尿病,脂质失调和代谢综合征同时发生.
- 传统上被视为肝脏特异性疾病,NAFLD现在被认为是动脉样硬化心血管疾病的独立风险因素.
研究的目的:
- 突出NAFLD作为心血管疾病显著风险因素的低估作用.
- 讨论目前用于管理NAFLD及其相关心血管并发症的治疗策略.
- 强调需要对最佳预防和治疗方案进行进一步研究.
主要方法:
- 对NAFLD流行情况的当前流行病学数据的审查.
- 对NAFLD与心血管疾病风险之间的关联进行分析.
- 对NAFLD和并发性疾病的现有治疗干预措施的评估.
主要成果:
- NAFLD是动脉样硬化心血管疾病的主要独立预测因子,是受影响个体死亡的主要原因.
- 生活方式干预 (减肥,运动,饮食) 和伴随疾病的管理对于减轻风险至关重要.
- 对伴随性疾病的最佳医学疗法是必不可少的,但单独是不够的.
结论:
- 乳腺炎是心血管疾病的关键,经常被忽视的风险因素,需要全面的管理方法.
- 对于患有NAFLD的患者,需要针对肝脏和心血管健康的综合策略.
- 进一步的研究是必不可少的,以建立最终的治疗指南,以预防NAFLD相关的肝脏和心血管并发症.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
